Average Co-Inventor Count = 5.22
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (7 from 3,923 patents)
2. Hoffmann-la Roche Inc. (5 from 4,942 patents)
3. Skyphy Networks Co., Ltd (1 from 1 patent)
4. Skyphy Networks Communication(shanghai) (1 from 1 patent)
5. F. Hoffmann-la Roche Ag (168 patents)
13 patents:
1. 12012420 - Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate
2. 12012421 - Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate
3. 11873302 - Solid forms of a compound of HBV core protein allosteric modifier
4. 11230559 - Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetate
5. 11142534 - Process for the preparation of 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds
6. 10507201 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
7. 10463653 - Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
8. 10130629 - Pharmaceutical combinations
9. 9896449 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
10. 9802917 - Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide
11. 9533988 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
12. 9266883 - Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
13. 8792389 - Rapid deployment devices in wireless self-organizing networks and methods for same